Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-26 @ 3:17 AM
Study NCT ID:
NCT05223920
Status:
COMPLETED
Last Update Posted:
2025-09-22
First Post:
2021-08-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)
Sponsor:
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-22
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-31
First Submit QC Date:
None
Study First Post Date:
2022-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-08-14
Results First Submit QC Date:
None
Results First Post Date:
2025-09-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-17
Last Update Post Date:
2025-09-22
Last Update Post Date Type:
ESTIMATED